177 related articles for article (PubMed ID: 2007144)
1. Chemical synthesis, purification, and characterization of two inflammatory proteins, neutrophil activating peptide 1 (interleukin-8) and neutrophil activating peptide.
Clark-Lewis I; Moser B; Walz A; Baggiolini M; Scott GJ; Aebersold R
Biochemistry; 1991 Mar; 30(12):3128-35. PubMed ID: 2007144
[TBL] [Abstract][Full Text] [Related]
2. Structural requirements of platelet chemokines for neutrophil activation.
Yan Z; Zhang J; Holt JC; Stewart GJ; Niewiarowski S; Poncz M
Blood; 1994 Oct; 84(7):2329-39. PubMed ID: 7919350
[TBL] [Abstract][Full Text] [Related]
3. Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils.
Walz A; Dewald B; von Tscharner V; Baggiolini M
J Exp Med; 1989 Nov; 170(5):1745-50. PubMed ID: 2681518
[TBL] [Abstract][Full Text] [Related]
4. High- and low-affinity binding of GRO alpha and neutrophil-activating peptide 2 to interleukin 8 receptors on human neutrophils.
Schumacher C; Clark-Lewis I; Baggiolini M; Moser B
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10542-6. PubMed ID: 1438244
[TBL] [Abstract][Full Text] [Related]
5. A synthetic peptide which specifically inhibits heat-treated interleukin-8 binding and chemotaxis for neutrophils.
Miller EJ; Kurdowska A; Nagao S; Carr FK; Hayashi S; Atkinson MA; Cohen AB
Agents Actions; 1993 Nov; 40(3-4):200-8. PubMed ID: 8023744
[TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide-stimulated human monocytes secrete, apart from neutrophil-activating peptide 1/interleukin 8, a second neutrophil-activating protein. NH2-terminal amino acid sequence identity with melanoma growth stimulatory activity.
Schröder JM; Persoon NL; Christophers E
J Exp Med; 1990 Apr; 171(4):1091-100. PubMed ID: 2182761
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships of interleukin-8 determined using chemically synthesized analogs. Critical role of NH2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis, and receptor binding activities.
Clark-Lewis I; Schumacher C; Baggiolini M; Moser B
J Biol Chem; 1991 Dec; 266(34):23128-34. PubMed ID: 1744111
[TBL] [Abstract][Full Text] [Related]
8. IL-1 alpha or tumor necrosis factor-alpha stimulate release of three NAP-1/IL-8-related neutrophil chemotactic proteins in human dermal fibroblasts.
Schröder JM; Sticherling M; Henneicke HH; Preissner WC; Christophers E
J Immunol; 1990 Mar; 144(6):2223-32. PubMed ID: 2179408
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil-activating properties of the melanoma growth-stimulatory activity.
Moser B; Clark-Lewis I; Zwahlen R; Baggiolini M
J Exp Med; 1990 May; 171(5):1797-802. PubMed ID: 2185333
[TBL] [Abstract][Full Text] [Related]
10. Purification, crystallization and preliminary X-ray diffraction analysis of recombinant human neutrophil-activating peptide 2 (rhNAP-2).
Kungl AJ; Machius M; Huber R; Schwer C; Lam C; Aschauer H; Ehn G; Lindley IJ; Auer M
FEBS Lett; 1994 Jun; 347(2-3):300-3. PubMed ID: 8034022
[TBL] [Abstract][Full Text] [Related]
11. The neutrophil-activating proteins interleukin 8 and beta-thromboglobulin: in vitro and in vivo comparison of NH2-terminally processed forms.
Van Damme J; Rampart M; Conings R; Decock B; Van Osselaer N; Willems J; Billiau A
Eur J Immunol; 1990 Sep; 20(9):2113-8. PubMed ID: 2145175
[TBL] [Abstract][Full Text] [Related]
12. Production and characterization of monoclonal antibodies against the novel neutrophil activating peptide NAP/IL-8.
Sticherling M; Schröder JM; Christophers E
J Immunol; 1989 Sep; 143(5):1628-34. PubMed ID: 2668411
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil-activating proteins in psoriasis.
Schröder JM; Gregory H; Young J; Christophers E
J Invest Dermatol; 1992 Feb; 98(2):241-7. PubMed ID: 1732389
[TBL] [Abstract][Full Text] [Related]
14. Cytokine-stimulated human mesothelial cells produce chemotactic activity for neutrophils including NAP-1/IL-8.
Goodman RB; Wood RG; Martin TR; Hanson-Painton O; Kinasewitz GT
J Immunol; 1992 Jan; 148(2):457-65. PubMed ID: 1309557
[TBL] [Abstract][Full Text] [Related]
15. Formation of neutrophil-activating peptide 2 from platelet-derived connective-tissue-activating peptide III by different tissue proteinases.
Car BD; Baggiolini M; Walz A
Biochem J; 1991 May; 275 ( Pt 3)(Pt 3):581-4. PubMed ID: 2039437
[TBL] [Abstract][Full Text] [Related]
16. Isolation, characterization, and immunological detection of neutrophil-activating peptide 2: a proteolytic degradation product of platelet basic protein.
Holt JC; Yan ZQ; Lu WQ; Stewart GJ; Niewiarowski S
Proc Soc Exp Biol Med; 1992 Feb; 199(2):171-7. PubMed ID: 1531540
[TBL] [Abstract][Full Text] [Related]
17. Chemotactic activity and receptor binding of neutrophil attractant/activation protein-1 (NAP-1) and structurally related host defense cytokines: interaction of NAP-2 with the NAP-1 receptor.
Leonard EJ; Yoshimura T; Rot A; Noer K; Walz A; Baggiolini M; Walz DA; Goetzl EJ; Castor CW
J Leukoc Biol; 1991 Mar; 49(3):258-65. PubMed ID: 1997632
[TBL] [Abstract][Full Text] [Related]
18. [Ca2+]i changes and respiratory burst in human neutrophils and monocytes induced by NAP-1/interleukin-8, NAP-2, and gro/MGSA.
Walz A; Meloni F; Clark-Lewis I; von Tscharner V; Baggiolini M
J Leukoc Biol; 1991 Sep; 50(3):279-86. PubMed ID: 1856598
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil-activating polypeptides IL-8 and NAP-2 induce identical signal transduction pathways in the regulation of lysosomal enzyme release.
Petersen F; Van Damme J; Flad HD; Brandt E
Lymphokine Cytokine Res; 1991 Apr; 10(1-2):35-41. PubMed ID: 1651769
[TBL] [Abstract][Full Text] [Related]
20. The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes.
Larsen CG; Anderson AO; Appella E; Oppenheim JJ; Matsushima K
Science; 1989 Mar; 243(4897):1464-6. PubMed ID: 2648569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
